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Aftercare
The support services available to young people who
complete custodial or community sentences, and/or
leave treatment. Specialist substance misuse
treatment is among these services.
Brief interventions
A single-session intervention to encourage longer
term treatment or self-reflection. Sessions last for up
to one hour and involve general motivational
interviewing techniques (see below).
Care plan
A document developed jointly by the practitioner,
the young person, their parent or carer, and any
other relevant professionals. It sets out the young
person’s goals, how they will be achieved, and who
is responsible for taking particular action. The plan
must meet the young person’s individual needs and
is reviewed regularly to ensure it remains relevant.
Class A drugs
Drugs that are considered to be the most harmful,
and which are controlled under the Misuse of Drugs
Act 1971. They include heroin and cocaine.
Cognitive Behavioural Therapy (CBT)
A therapy that focuses on understanding the roots
of problem behaviour. It can help young people to
develop coping mechanisms for modifying and
reducing such behaviour, and promotes rational
belief as a way of achieving change and health.
Conduct disorder
A mental health term to describe young people who
repeatedly violate the personal or property rights of
others and the basic expectations of society. Only a
GP can make a diagnosis of conduct disorder,
usually when the symptoms continue for six months
or longer.
Dual diagnosis
The combination of mental illness and drug/alcohol
misuse.
Externalising symptoms
A group of mental health symptoms and conditions
that are projected onto the environment, such as
conduct disorder or attention deficit hyperactivity
disorder (ADHD).
Harm reduction
A collective term for the policies, programmes and
projects that aim to reduce the negative health
effects associated with the use of psychoactive
substances. It is a targeted approach that focuses on
specific effects related to specific substances.
‘Specialist harm reduction’ is an NTA term for
initiatives aimed at young people. The complexity of
this intervention and the possibility of severe harm
means it should be provided only by a specialist
young people’s treatment practitioner. In this
document ‘specialist harm reduction’ relates to three
specific areas: needle exchange for injecting drug
users; immediate drug-related deaths; and physical
injuries associated with substance misuse.
Internalising symptoms
A term used to group mental health symptoms and
conditions directed towards the individual suffering
from them, such as depression or anxiety.
Motivational interviewing
A client-centred counselling style, which encourages
them to consider their personal values and goals,
and to reflect on the risks associated with substance
misuse.
Multi-dimensional family therapy
This uses a multi-systemic approach (see below) to
address the risk factors and promote the protective
elements that operate on many levels between
young people, their families and other people in
their lives, such as school teachers.
Multi-systemic therapy
Interventions that look at the individual, family, peer
group, school and social networks associated with a
young person’s problems. It uses evidence-based,
solution-focused interventions, such as strategic
family therapy and CBT. Multi-dimensional family
therapy is also based on this framework.
Psychoeducational
Intervention that focuses on the physiological
consequences of substance misuse. The therapist
works with the young person to understand the
effects of substances and to make choices based on
that understanding.
Psychosocial
Intervention that uses psychological and
psychotherapeutic counselling and counselling-
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Glossary
based techniques to encourage behavioural and
emotional change, and to promote lifestyle
adjustments and coping skills. It also includes
motivational interviewing, relapse prevention and
interventions designed to reduce or stop substance
misuse. Additional intervention addresses the impact
of substance misuse on offending and education,
employment or training.
Substance
The term for illicit and illegal drugs, alcohol, solvents
(or volatile substances), except for tobacco.
Therapeutic alliance
The collaborative bond between a therapist and a
young person. In family interventions it is between
the therapist and the young person’s parents.
Therapeutic community
A model of residential substance misuse treatment
that uses positive peer role models and the peer
community to promote social and psychological
change. It may also use confrontational elements.
Transition
When a young person moves from one service to
another. This can be from young people’s services to
adult services, residential services to community
services, or specialist services to universal services.
Young people/young person
In this document, anybody under 18 years of age. In
other documents, ‘child’ is sometimes used. Where
statements have been extrapolated from these
documents the term ‘child’ or ‘children’ is used.
Abbreviations
NTA: National Treatment Agency for
Substance Misuse
NICE: National Institute for Health and
Clinical Excellence
YJB: Youth Justice Board for England
and Wales
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This report is aimed at professionals who provide
specialist substance misuse treatment services for
young people under 18 years old. The National
Treatment Agency for Substance Misuse (NTA)
defines young people’s treatment as, “care planned
medical, psychosocial or specialist harm reduction
interventions aimed at alleviating current harm
caused by a young person’s substance misuse.”
This report brings together evidence for effective
treatment of substance misuse among young people
aged 18 and under. It was developed from literature
reviews and primary research published in peer
review journals, which focus on substance misuse
among this age range (see Methodology for details).
The report has been produced as part of the Youth
Alcohol Action Plan’s commitment to improve
alcohol treatment for young people (Department for
Children, Schools and Families, Home Office and
Department for Health, 2008).
The aim of the report is to synthesise the current
evidence base specifically related to young people’s
substance misuse and suggest good practice points
that arise from this. Practitioners and commissioners
are encouraged to use the good practice points in
the development of local specialist substance misuse
services for young people.
Evidence of effectiveness
Young people’s substance misuse is a relatively new
area of academic study; traditionally studies have
focused on vulnerabilities to substance misuse and
education and prevention initiatives. Research on
effective treatment interventions is still scarce but is
growing both in quantity and quality. In the past
good practice reports have been based on an
extrapolation of adult based research and evidence
in relation to working with young people in other
areas of health or social care. 
This guide is intended to: 
 Familiarise practitioners with the evidence
specific to young people and substance misuse   
 Use this evidence to highlight and promote
elements of good practice
The evidence selected for this report was chosen
systematically from a thorough search of peer-
reviewed published research papers and grey
literature. Each piece of evidence was evaluated
according to specific criteria designed to select the
highest quality of research available. Two scales
were used, which ranged in points from 0-5 with
five being the highest score. Only those achieving
grade 3 or above are included in this report. Further
details about the strength of evidence and
methodology for the systematic review are described
in the appendix. 
All the evidence used is based on research
conducted specifically with young people under 18
years old (unless otherwise stated) ensuring that this
report is geared to providing good practice points
developed from work with young people. 
Limitations to the evidence
Evidence specific to young people and substance
misuse treatment is still scarce. There is too little
research to make strong statements about definite
treatment decisions, so the information provided is
intended to be indicative of promising practice. This
report does not have the same status as guidance
published by the National Institute for Health and
Clinical Excellence (NICE). The studies referred to in
this report have been selected for their quality (see
Methodology) but most of the topics can draw on
only a handful of studies, or less, which is not ideal
for making broad statements. Rather the evidence
and the good practice points presented should be
used to guide service development in the direction
of the evidence based findings currently available. 
Much more research needs to be done before firm
statements can be made about what is, or is not,
effective in young people’s substance misuse
treatment. It is not possible to find quality studies on
some interventions. This does not mean they have
no value, or that they do, they have not been
thoroughly tested yet. Interventions that seem to be
working well in your setting (i.e. there is local
anecdotal evidence) should not be abandoned
purely because they are not represented in this
guide, but they should be treated with caution. This
guide can be used to steer future interventions and
developments but it is recognised that as research
develops other types of intervention may well be
added to the effectiveness portfolio. 
Most of the research on young people and
substance misuse has been conducted in North
America, which is different from England both in
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Introduction
terms of culture and service provision. Throughout
the report any evidence from the UK is stipulated.
Generally research looks at those using ‘substances’
or ‘alcohol and other drugs’, this no doubt reflects
the mixed substance use patterns of young people. 
As ever, services should be re-appraised against new
evidence as it is published. It is hoped that new
findings can be brought to you in future years and
that organisations can collaborate with UK research
projects to develop the evidence base further.
Research other than young people’s substance
misuse treatment is likely to be useful but falls
outside the scope of this guide. This includes
effectiveness of adult drug and alcohol treatment
interventions and interventions to help young people
who have high needs and multiple vulnerabilities.
Commissioning context
Health and social care services for young people are
commissioned and developed by children’s trusts in
each local authority area in collaboration with local
primary care trusts (PCTs). Depending on a young
person’s needs they will be offered services at a
universal, targeted or specialist level. 
 Universal – accessible by all young people, such
as schools and family doctors
 Targeted – accessible by young people who are
considered to be vulnerable or who have been
identified as having needs that require some low
intensity intervention and monitoring (such as
social inclusion programmes)
 Specialist – accessible by young people with
identified needs that cannot be met by universal
or targeted provision (such as mental health
services, specialist schools, in-patient services,
substance misuse treatment services)
 Young people should have their needs identified
and met in universal or targeted services
wherever possible. However, specialist substance
misuse treatment services should be offered to
all young people whose substance misuse is
currently significantly impairing their physical,
psychological and/or social functioning, and who
have been assessed as requiring treatment to
change their substance misuse. This document is
solely concerned with specialist substance misuse
treatment interventions 
 There are a number of policy documents that
can support the commissioning of young
people’s specialist substance misuse treatment,
including Department of Health (2007) You’re
Welcome Quality Criteria and National Treatment
Agency (2008a) interim Commissioning Young
People’s Specialist Substance Misuse Treatment
Services. 
Providing specialist substance
misuse treatment
Informed guidance and consensus about good
practice suggests there are a number of conditions
that should be met before providing specialist
substance misuse treatment to young people. They
are summarised below and a reference to more
detailed documents is given. 
 Assessment should always take place before an
intervention
 Risk assessments are a vital first stage in
assessment
 Young people should have an individual care
plan that addresses the needs identified in the
assessment
 Multiple professionals and services may be
required to meet young people’s needs which
are often complex, multiple and extend beyond
the remit of specialist substance misuse services 
 Care should be coordinated across services by an
identified lead professional and in line with
arrangements sent out in guidance on the
Common Assessment Framework
 Young people have a right to be safeguarded
from harm and as such child protection issues
should be explored and addressed if identified
 Some young people can consent to their own
treatment (i.e. when they are assessed as
competent to do so). Others will require their
parents’ consent prior to treatment interventions
 Young people should be encouraged to allow
parents and carers to participate in their
treatment plans. However where this is not
achievable young people can expect
confidentiality from health care providers,
though this may limit the service that they can
receive due to consent issues. 
 Young people should have their views taken into
account. This is both in terms of the treatment
they receive and the design and delivery of the
service. These issues are explained in more depth
in Assessing Young People for Substance Misuse
(NTA, 2007a).
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This section explores the current interventions that
are specifically referred to in the evidence base, and
are likely to be monitored by the NTA as specialist
treatment. NTA definitions of types of specialist
substance misuse treatment interventions for young
people are shown in Box 3. Research studies have
been grouped to explore the evidence base for each
definition, where possible. Substance misuse
treatment should only be undertaken by
professionals who are trained in their delivery and
who have access to professional supervision. They
are intended to be delivered in a specialist substance
misuse treatment setting for young people.  
Overview of specialist substance
misuse treatment 
Substance misuse treatment for young people has
consistently been shown to be effective in reducing
substance misuse in medium-term outcome studies
(Dasinger et al 2004, Dennis et al 2004, Farabee et
al 2001, Godley et al 2004, Morral et al 2004, 2006,
Ruiz et al 2005, and Waldron et al 2001). The
treatment interventions used in these studies are
wide ranging, from residential to community
interventions, and demonstrate a number of
techniques and combinations of techniques
described in other sections of this report. 
Different treatment interventions were compared to
each other in these long-term outcome studies (see
Study 1 and 2). No intervention was significantly
better than any other, all were able to demonstrate
effectiveness. However, sticking to an intervention
model based on theoretical and empirical
effectiveness has been shown to increase retention
in substance misuse treatment programmes
compared to simply the amount of time spent with a
young person (Noel, 2006). There is little evidence
on which treatment interventions best suit different
young people (Godley et al, 2004).
Many young people were involved in these studies
and they had a similar substance misuse profile to
young people attending specialist substance misuse
treatment services in England, i.e. predominantly
cannabis and alcohol misuse, with some using other
substances such as heroin and cocaine. Many were
poly-substance misusers and all were in specialist
treatment settings. The studies used large samples,
the smallest being 114 young people, the largest
over 1500, and looked at outcome measures after at
least seven months from the start of treatment to 30
months after treatment commenced, with the
majority considering outcomes at 12 month post
initiation of treatment. In Scotland a range of
community based specialist substance misuse
interventions were studied and were able to
demonstrate effectiveness over an eight month
period (McIntosh et al, 2006). Two of the larger
studies are illustrated in Study 1 and 2 to show the
people who took part, the interventions that were
compared and the major findings. 
Treatment effectiveness studies are sometimes
criticised for using manual-based programmes and
skilled professionals, which do not reflect the reality
of normal substance misuse treatment (Liddle et al,
2002). For this reason the studies by Farabee et al
(2001) and Morral et al (2004, 2006) researched
normal, widely available treatment approaches in
the USA, rather than treatment setup for research
purposes. These studies were still able to
demonstrate treatment effectiveness. 
In addition to reducing substance misuse the
effectiveness of interventions has been
demonstrated in a number of other outcomes:
 Reduced problem behaviour (McIntosh et al,
2006)
 Increased involvement in positive activities
(McIntosh et al, 2006)
 Increased confidence and self-esteem (McIntosh
et al, 2006)
 Improved academic attainment (Liddle et al,
2001),
 Reduced criminal activity (Henggeler, 2002;
2006) 
 Improved mental health (Liddle et al, 2004)
 Improved family relationships (Liddle et al, 2004;
McIntosh et al, 2006)
 Improved attendance at school (McIntosh et al,
2006)
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Study 1: The Cannabis Youth Trial
The Cannabis Youth Trial (Dennis et al, 2004)
recruited 600 young people and their families.
The young people, aged 12-18, met Diagnostic
and Statistical Manual of Mental Disorders-IV
(DMS-IV) criteria for cannabis abuse or
dependence. Some also had alcohol or other drug
problems and/or mental health problems, but
were excluded if these were dominant. However,
among those recruited 95% had one or more
problems in addiction to cannabis misuse and
84% had three or more additional problems
related to other substances or mental health
problems. Needs were measured using the Global
Appraisal of Individual Need scale.
All the treatment interventions were provided in a
community (outpatient) setting. Each young
person was randomly allocated to one of five
treatment conditions (none lasted over 90 days):
 Two sessions of individual motivational
enhancement therapy and three sessions of
group cognitive behavioural therapy over six
to seven weeks (MET/CBT5)
 Two sessions of individual Motivational
Enhancement Therapy and ten sessions of
group Cognitive Behavioural Therapy over 
12-14 weeks (MET/CBT12)
 Family Support Network (FSN) – MET/CBT12,
plus six parent education group meetings,
four therapeutic home visits, referral to self-
help groups and case management to
promote engagement in the process
 Adolescent Community Reinforcement
Approach (ACRA), which combines operant
conditioning, skills training and a social
systems approach – ten individual sessions
with the young person, four sessions with the
parents (two whole family sessions) and some
case management over 12-14 weeks
 Multi-Dimensional Family Therapy (MDFT) –
based on linking reductions in drug and
problem behaviour with changes in parenting
practice and improved therapeutic alliance -
12-15 sessions (typically six with the young
person, three with the parents and six with
the whole family)
Staff were experienced and highly trained
clinicians (all were graduates, most had
masters or doctoral degrees), but not
accustomed to using manual guided therapy.
All received weekly clinical supervision
sessions. 
Outcome measures were:
 Days of abstinence from cannabis, alcohol
and other drugs, from the start of treatment
to the 12-month follow-up date
 No drug or alcohol use in the last month
leading to the 12-month review while living in
the community in a non-controlled
environment.
All five Cannabis Youth Trial interventions
showed positive results in terms of increased
number of days abstinent from cannabis, alcohol
and other drugs over a 12 month period and no
drug or alcohol use in the last month of the
study. Outcomes were similar across the 5
interventions. Cost effectiveness was also
examined as the costs of interventions varied
widely. MET/CBT5, MET/CBT12 and ACRA were
more cost effective than FSN and MDFT.  
Good practice points
 Studies have shown that specialist treatment
interventions are effective in reducing
substance misuse among young people
 From the current evidence base, it is not
possible to say which treatments are better
than others in reducing substance use 
 Using a specialist treatment technique that 
is evidence-based appears to reduce drop 
out rates 
 Specialist treatment appears to bring benefits
to areas of a young person’s life beyond their
substance misuse.
Specialist substance misuse
treatment interventions for young
people: NTA definitions 
1. Pharmacological 
These interventions include prescribing for
detoxification, stabilisation and symptomatic relief of
substance misuse as well as prescribing of
medications to prevent relapse.  
2. Psychosocial 
These interventions use psychological,
psychotherapeutic, counselling and counselling-
based techniques to encourage behavioural and
emotional change, the support of lifestyle
adjustments and the enhancement of coping skills.
They include motivational interviewing, relapse
prevention and interventions designed to reduce or
stop substance misuse, as well as interventions
which address the negative impact of substance
misuse on offending and attendance at education,
employment or training. 
3. Family 
Interventions using psychosocial methods to support
parents, carers and other family members to
manage the impact of a young person’s substance
misuse, and enable them to better support the
young person in their family. This includes work with
siblings, grandparents, foster carers, etc. and can be
provided even if the young person misusing
substances is not currently accessing specialist
substance treatment.
4. Specialist harm reduction 
Specialist harm reduction interventions should
include services to manage:
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Study 2: The USA RAND Corporation study 
The Rand Corporation study examined the
effectiveness of ten adolescent substance misuse
programmes (Morral et al, 2006). It involved a
large number of young people (1,261 in the
treatments being evaluated plus 284
comparisons) in three types of interventions:
 Long-term residential facilities, these had
programmes that ran between six to12
months
 Short-term residential facilities, these had
programmes that ran between 30-50 days;
one was a specialist culturally specific service
for Native Americans
 Community programmes, these varied in
intensity from one to 12 hours’ contact per
week and tended to be a mixture of individual
and group settings.
The programmes were chosen because they were
thought to represent ‘good practice’ based on
previous research and theoretical evidence. Needs
were measured using the Global Appraisal of
Individual Need scale.
Outcome measures were:
 No drug or alcohol use while living in the
community in a non-controlled environment
 Substance problems
 Substance use frequency
 Illegal activities
 Emotional problems
 Days in a controlled environment, such as in
custody or a closed residential facility
All the young people who presented for the
programme could be included provided that they
consented and that 12-month follow-up
assessments were available. Rather than simply
comparing the effectiveness of the programmes,
which may not account for differences between
young people attending the programmes, case-
mix analysis was used. This used statistical
procedures to look at the effectiveness of
programmes in relation to a range of factors
affecting young people using the same outcomes.
The treatment interventions were not found to
differ significantly from each other in terms of
effectiveness after case-mix analysis was
conducted, however all of the treatments were
found to be effective.
a. Injecting – young people need to be able to
access specific injecting services, as adult services
for injectors are too low threshold and will put
young people in contact with adult drug-service
users, both of which may put them at further
risk of harm. These services could include needle
exchange, advice and information on injecting
practice, access to appropriate testing and
treatment for blood borne viruses and
participation in full assessment and other
specialist substance misuse treatment services.
b. Overdose – advice and information to prevent
overdose, especially overdose associated with
poly-substance use, which requires specialist
knowledge about substances and their
interactions. This could include protocols with
accident and emergency services to ensure that
measures to identify and prevent future overdose
are in place.
c. Accidental injury – protocols with accident and
emergency services to ensure that measures to
identify and prevent future substance misuse
related accidental injuries are in place.
5. Residential treatment for
substance misuse 
Any specialist substance misuse intervention (as
defined in 1-4 above) provided in a residential
setting where the young person has been placed,
away from their usual home, specifically in order to
decrease levels of risk from substance misuse and to
gain access to highly intensive young people’s
specialist substance misuse interventions.
1. Pharmacological 
There is little evidence on pharmacological treatment
with young people to manage substance misuse
(Bukstein and Cornelius, 2006). This has been due to
the very low numbers of young people requiring
pharmacological management of substance misuse,
and ethical and legal considerations of conducting
drug trials with those under 18 years of age. 
There are a number of approaches to using
pharmacology with substance misusers:
 To treat withdrawal symptoms
 To provide substitution therapy 
 To reduce craving and block effects of
substances.
These approaches are widely used in adult
populations and there is a substantial evidence base
for them. Professionals should be familiar with NICE
(2007a; 2007b; 2007d) and Department of Health
(2007b) guidelines on the management of drug and
alcohol use which provide a synthesis of the research
and make recommendations. 
These strategies can be adopted with young people
but only with caution, as there are a range of factors
which makes simple transfer of adult models to
young people problematic. These include:
 Medications have not been tested in adolescent
populations
 Young people tend to have shorter histories of
substance use and have used lower levels for
shorter periods
 Effects of the medication on physical and mental
health of young people are uncertain
 Medications can themselves be misused and
have potentially fatal consequences
 Young people’s bodies are not fully developed,
low body mass and underdeveloped organs may
contribute to increased adverse effects
 The factors listed above make gaining the
informed consent to treatment (from the parent
or young person depending on competence) a
complex but vital process. 
In addition young people requiring pharmacological
management for substance misuse may have mental
health conditions which also require
pharmacological management. The evidence base
for treating these two conditions simultaneously has
gaps in the adult treatment and is severely
underdeveloped in young people (Bukstein and
Cornelius, 2006). Consequently professionals are
encouraged to work in partnership with
professionals competent in young people’s mental
health issues where young people have both a
mental health and substance misuse problem.  
An extensive good practice report on undertaking
pharmacological interventions with young people
will be published shortly by the NTA. It will take into
account recent guidelines from the Department of
Health (2007b) and NICE (2007a; 2007b; 2007d);
extensive evidence from adult populations; good
practice and anecdotal evidence from experienced
clinicians working with young people; information
on gaining consent for treatment; the licensing of
medications for substance misuse and use of off-
label medication. 
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2. Formal psychosocial
interventions
A number of specific psychosocial interventions have
been highlighted here as a reflection of the evidence
base, however they are not intended to be the only
psychosocial interventions that can be used.
The majority of interventions delivered in specialist
services to young people in England are psychosocial
in nature. The following sections present the
evidence for these interventions in relation to young
people. There is some over-lap between evidence
and good practice points presented here and that
published by NICE. There are also differences. The
NICE (2007c) public health intervention guidance
focuses on community interventions that target
young people at risk of substance misuse, while this
report focuses on interventions for those with
established misuse. The NICE (2007e) guidance on
psychosocial interventions, while applicable to those
aged 16 and over, primarily focuses on adults and is
based on a predominantly adult evidence base.
Familiarity with the NICE documents is encouraged. 
Cognitive behavioural therapy
The evidence base for the use of CBT for young
people’s mental health conditions such as conduct
disorders, depression and anxiety is well established
(Waldron and Kaminer, 2004). NICE (2007e)
(psychosocial interventions for substance misuse for
those over 16 years) states that CBT for drug misuse
should not be offered routinely to people presenting
for treatment of cannabis or stimulant misuse or
those receiving opioid maintenance treatment.
However, as previously stated, this is based
predominantly on an adult-orientated evidence base
and on drugs rather than substances. NICE (2007c)
(public health guidance for community interventions
for vulnerable young people) recommends the use
of behavioural therapy and Heather, Raistrick and
Godfrey (2006) (review of effectiveness of treatment
for adult alcohol problems) suggest that CBT
approaches to specialist alcohol treatment offer the
best chance of success. The situation is therefore
confusing in relation to making recommendations
for specialist interventions for young people who
often have a pattern of alcohol and drug use. 
In relation to evidence specifically developed from
studying young people with alcohol and drug
problems (including those who use a range of
substances) there is growing evidence that the use
of CBT is effective. Waldron and Kaminer (2004)
conducted a systematic review of research exploring
CBT used for treating young people’s substance
misuse. They concluded that out-patient CBT
treatment can be effective in reducing substance
misuse as well as other related problems. However,
they suggest that CBT should be adapted to the
different developmental stages of young people
from adults. This may include the negotiation of
privileges and adding components to develop basic
social and coping skills of young people. 
Kaminer et al, (2002) found short-term outcomes
(three months post-treatment) were better for
young people who had received CBT rather than
psychoeducational therapy, but only for older youths
(16-18 years) and males. This advantage was not
found over a longer period of nine months, where
psychoeducational therapy performed as well as
CBT.
In their systematic review Waldron and Kaminer
(2004) found two studies of group CBT which
proved as effective as individual CBT. Kaminer and
Waldron (2006) suggest that some components of
group work may facilitate change. These include
realising that others share similar problems,
development of social skills, modelling, rehearsal and
peer feedback. They suggest that role playing is
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Good practice points
 There is solid evidence that pharmacological
management of substance misuse is effective
among adults, but it must be undertaken
with caution with young people
 Pharmacological management can control
withdrawal symptoms, provide substitution
therapy and reduce cravings
 Young people’s response to pharmacological
management cannot be totally predicted as
there have been no controlled trials. Also, the
medication can itself be dangerous if misused
 Gaining informed consent from parents or
young people (where they are competent) is
a vital task before any treatment starts, but
especially for pharmacological management.
To give informed consent, a person must
understand the possible negative effects of
treatment as well as its benefits
 Treating both substance misuse and mental
health issues with medication is highly
complex. It should only be undertaken by
professionals with competence in both areas,
or as part of a multi-disciplinary team that
holds the necessary competencies.
particularly suited to a group setting and can mirror
daily experiences, allowing the practice of coping
with high risk experiences.
Brief interventions and motivational
interviewing
In the majority of research reports ‘brief
interventions’ are described as single sessions lasting
no more than one hour. Brief interventions are used
to encourage self-reflection. They can be used as
interventions in their own right among those whose
needs are not great, but for other young people
engagement with more intense substance misuse
treatments can also be a goal. Motivational
interviewing techniques are usually used in brief
interventions. Motivational interviewing is a client
centred counselling style, which aims to encourage
reflection on the risks associated with behaviours
such as substance misuse in the context of personal
values and goals.
Motivational interviewing and brief interventions
have been effective in a range of contexts:
 To reduce alcohol use (Gray et al, 2005; Tevyaw
and Monti, 2004) 
 In accident and emergency departments to
reduce substance misuse and increase
attendance at specialist substance misuse
treatment service (Tait et al, 2004, 2005)
 In custodial settings to increase engagement
(Stein et al, 2006)
 In college settings to reduce substance use
(McCambridge and Strang, 2004)
Multi-systemic therapy
Multi-systemic interventions focus on the individual,
family, peer, school and social networks that are
linked with identified problems, using evidence-
based, solution focused interventions, such as
strategic family therapy and cognitive behavioural
therapy. Multi-dimensional family therapy (MDFT) is
also based on this theoretical framework. MDFT
targets multiple risk and protective factors and
multiple domains of adolescent and family
functioning.
There has been increasing activity in relation to
multi-systemic therapies including MDFT recently.
Initial results are promising with substance misuse
reducing more quickly than with other interventions
in the first three months (Liddle et al, 2001; Waldron
et al, 2001). This reduction in substance misuse can
last up to 12 months (Liddle et al, 2001) but by this
time other interventions are providing comparable
results (Liddle et al, 2001; Waldron et al, 2001). 
Multi-systemic therapy has been shown to be
effective in reducing substance misuse among young
people with low levels of substance misuse and
short offending histories (Liddle et al, 2004) and
among those with established patterns of substance
misuse and more established patterns of criminal
activity (Henggeler et al, 2006). 
Multi-systemic therapy has produced better
outcomes in terms of substance misuse and criminal
activity than weekly group work (Henggeler et al,
2002; 2006) and these effects may be even higher if
combined with contingency management
components (Henggeler et al, 2006). Improvements
were also shown in relation to completion of the
intervention, family cohesion and externalising
mental health symptoms (Henggeler et al, 2006).
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Good practice points
 Familiarity with NICE (2007c; 2007e)
guidance on psychosocial interventions, and
the good practice points in this report, can
improve professionals’ knowledge of
evidence-based practice
 CBT has been found to be effective in
treating young people’s substance misuse 
 Providing CBT in a group setting may help
young people to role play and practice
coping with high-risk experiences. The group
setting allows young people to share similar
problems, develop social skills, model,
rehearse and gain peer feedback 
 Brief interventions using motivational
interview techniques can be used as one-off
sessions, or to facilitate engagement with
more structured specialist treatment
 Multi-systemic therapies have been found to
be effective in helping young people who
have short and long histories of substance
misuse. Improvements have been found in
misuse levels, criminal activity, family
cohesion and some mental health problems
 Combining multi-systemic therapy with a
contingency management reward system
may increase the intervention’s effectiveness.
3. Family 
The need to involve family members, particularly
parents has been stressed in policy
recommendations for some time (SCODA/CLC,
1999) and recently emphasised in Every Parent
Matters (DfES, 2007) and in Supporting and
Involving Carers (NTA, 2008b). This is to gain any
necessary consent to treatment that may be required
and to engender the support of the family in helping
the young person achieve their treatment goals. 
Some parents may well lack effective coping skills
and find it difficult to engage with their child’s
substance misuse treatment due to their own
distress. Coping skills of parents can be improved in
treatment programmes. There is evidence to suggest
that when training courses are developed for
parents their substance misuse and psychological
coping improves, and the cannabis use of their
children reduces (McGillicuddy et al, 2001).
A study in Scotland found that involving parents and
carers improved the effectiveness of specialist
substance misuse treatment for young people
(McIntosh et al, 2006). This worked in two main
ways. Firstly greater information about the young
person was gained, which improved the
identification and meeting of the young person’s
needs and which services were already involved in
the young person’s care. Secondly, it provided
opportunities to mobilise the parents’ support, to
provide advice and information about substance
misuse and to discuss parents’ behaviour which may
be contributing to their child’s difficulties.
Parental participation in interventions may improve
the outcomes for children. Clark et al (2005) found
that young people in alcohol treatment were more
likely to do well if their parents provided supervision
than those with low parental supervision. 
The level of engagement the young person has with
an intervention appears to be affected by parental
involvement and family relations (Dakof et al, 2001).
Young people whose parents appreciated that their
child had a problem with substance misuse, but who
also demanded an end to this behaviour and
encouraged academic achievement engaged better
with interventions. This applied even where it
seemed unlikely that the young person would
actually do well at school. It is also important to
make sure that the young person appreciates they
have a problem to encourage engagement;
discussing the family conflict it causes is one way of
doing this (Dakof et al, 2001). 
4. Specialist harm reduction 
This section relates to interventions that the NTA
expects local areas to provide within specialist
substance misuse treatment. It relates to three
specific areas of evidence: needle exchange for
injecting drug users, immediate drug-related deaths,
and physical injuries sustained associated with
misuse. Other aspects of harm reduction, such as
advice on safer drinking, avoiding blood-borne
viruses and reducing sexually transmitted infections,
should be provided at universal and targeted levels
of support (as well as in specialist services) so are not
covered here. However, the aspects outlined below
should only be provided at a specialist level, hence
the term ‘specialist harm reduction’.
Needle exchange
Needle exchange provision has been the back bone
of UK harm reduction initiatives since the advent of
HIV and AIDS (ACMD, 1988). The implementation of
needle exchange and other harm reduction
initiatives has limited the spread of HIV infection in
the UK (Stimson, 1995). Recent research however,
has indicated that rates of blood-borne viruses
among injecting drug users is rising (Health
Protection Agency, 2006) and there is a renewed
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Good practice points
 Involving a young person’s family in his or her
treatment is beneficial in providing support to
the young person, and has been shown to
improve the effectiveness of treatment
 Providing support comprising information on
substances and parenting skills can improve
parents’ ability to cope with their child’s
problems and reduce substance misuse
among parents and their children 
 Involving family members allows
professionals greater access to the needs of
young people and facilitates a better
understanding of the context of the
development of the misuse problem 
 Practitioners should be aware of the different
risks posed when parents are also using
substances
 Young people’s greater appreciation of the
family conflict substance misuse causes,
combined with active encouragement to
attend treatment from parents, can aid
engagement with specialist treatment.
emphasis on the provision of harm reduction
initiatives (Department of Health, 2007a). 
The provision of needle exchange for young people
under the age of 18 has attracted some controversy,
both from those opposing its provision and those
supporting it. National policy in England has
supported the provision of needle exchange to
young people (SCODA/CLC, 1999; DrugScope,
2001; NTA, 2005), although this provision is set
within a different framework than that for adults.
Due to risks inherent in injecting drugs and the duty
of care we owe to young people, needle exchange is
conceptualised for young people in English drug
policy as part of one element of treatment,
undertaken only after a risk assessment, full
assessment, and as part of a care package, as
opposed to the low-threshold, often anonymous
provision that represents adult needle exchange.
This position is an attempt to balance the need for
harm reduction initiatives to reduce risks associated
with injecting with ensuring those who access
needle exchange get the appropriate support to
make changes to their drug taking behaviour.
Few studies have explored the provision of needle
exchange on the attitudes and behaviours of young
people. Kipke et al (1997) in the USA compared two
groups of ‘street youth’, one that used a needle
exchange facility and one that did not. ‘Street youth’
are described as young people not in education or
employment, runaways or homeless and/or involved
in gangs, drug-dealing or prostitution. They found
that the rate and type of drug use was similar in the
two groups but those using the needle exchange
practised safer injecting, such as less sharing of
syringes and other equipment, than those who did
not. The young people in this study were aged 16-
18 (23%), 19-21 (42%), and 22-24 (35%). The
younger members of the group were more likely to
be injected by someone else, and felt they could not
access clean sterile equipment as easily as the older
youths. This puts them at greater risk of blood-borne
viruses. A similar study (Guydish et al, 2000) among
young drug injectors with a mean age of 20
suggested most young injectors do not believe that
needle exchange either increases drug use, or
decreases treatment readiness, and that it may
decrease some HIV risk behaviour, such as access to
clean needles and reduced reuse of syringes. 
Providing needle exchange to young people appears
to be necessary to reduce the risk of blood-borne
virus transmission. Among young people (aged 15-
19) attending services in Ireland it was found that
after the first year of injecting, risk-taking behaviour
increased (Mullen and Barry, 2001). Thus providing
interventions early is likely to promote blood-borne
risk-reduction measures including injecting sharing
practices and sexual practices, which may be
particularly pertinent for young women (Mullen and
Barry, 2001). Providing services to young people
within a harm-reduction model has been shown to
be valuable among young people accessing needle
exchange facilities (Weiker et al, 1999). After initial
engagement to access clean needles, the young
people spent more time at the facility and could be
introduced to broader aspects of harm reduction.
The young people emphasised that not being
judged about their drug use increased their self-
esteem and feelings of self-worth.
Not only can needle exchange promote a reduction
in blood-borne virus risk behaviour, but a USA study
among school pupils found that seeing drug users
attending needle exchange could also be a deterrent
to drug use (Marx et al, 2001) and had at least a
neutral effect on youths who lived in the vicinity of a
needle exchange, rather than a detrimental one.
Drug-related deaths
The Office for National Statistics (ONS) reports on
drug-related deaths in England and Wales. In a
recent bulletin (ONS, 2007a) it stated that while
there had been a general downturn (9%) in the
number of drug-related deaths since 2000, it was
not enough to meet the government target of 20%.
The NTA (2007b) has published an action plan to
increase the rate of reduction in drug-related deaths.
The ONS collates the number of deaths due to
‘drug-poisoning’ which includes deaths where the
underlying cause is recorded as due to poisoning,
drug abuse and drug dependence, and includes only
those drugs controlled by the Misuse of Drugs Act
1971. In 2007 these deaths (which include all age
groups, including young people and adults) could be
broken down as resulting from a number of factors:
 33% accidental overdose
 45% drug dependence
 11% self-poisoning
 11% undetermined intent
 Less than 1% homicide.
In 2004 (ONS, 2007a) drug misuse was the third
most common cause of death among young adults
aged 15-35 years old, after traffic accidents and
suicide. However, deaths due to drug misuse among
those aged under 20 remain low compared to
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deaths in other age groups (ONS, 2007b). In 2006
there were 1,753 deaths due to drug use, of which
50 (3.2%) were aged 15-19. The number greatly
increases to 408 (26%) in the next age bracket, 20-
29. This suggests that increasing the preventative
messages to young people already using substances
before the age of 20 will not only avoid drug-related
deaths among young people but may also help
avoid later deaths from ‘drug poisoning’. 
In relation to volatile substance misuse (not covered
in the drug-related deaths statistics above) there has
been a general decline in deaths since 1992. Among
those under 18, there has been a fall from 13 in
2004 to six in 2006 despite the use of volatile
substances among school children remaining stable
at 5% for boys and 6% for girls (Field-Smith et al,
2008). Three of these deaths were associated with
aerosol misuse, two with butane cigarette lighter
refills (despite the sale of these being prohibited to
under 18s), and one with nitrous oxide which had
been obtained for non-medical use. In 2006 the
youngest person to die was 15. Field-Smith et al
(2008) suggest that Department of Health
advertising campaigns in conjunction with school-
based education programmes may have contributed
to the decline in deaths among young people.  
The NTA (2007b) Action Plan on Reducing Drug
Related Harm stresses the importance of reducing
deaths due to blood-borne viruses as well as from
drug poisoning. The Action Plan includes improving
access to hepatitis B vaccination, testing and
treatment for hepatitis B, C and HIV, and prevention
of drug-related deaths due to overdose and misuse.
Accidental injury
The National Information Centre (2007) of the NHS
has reported on alcohol statistics in England. During
2005/06 there were 4,060 admissions to A&E
departments of young people under 16 where the
primary diagnosis was specifically related to alcohol
consumption. This represents a 29% increase in ten
years. When secondary diagnosis related to alcohol
consumption is included this rises to 5,280, an
increase of 37% since 1995/96. Over half (59%) of
those under 16 were girls. The majority of primary
diagnosis related to alcohol consumption were
mental and behavioural disorders associated with
alcohol, most of the other admissions were due to
the toxic effect of alcohol consumption. 
Hansard (2008) reported that in 2006/07 there were
13,976 hospital admissions in England of young
people under 15 where the primary or secondary
diagnosis was related to drugs. This represents a
slight decrease from the previous four years when
figures varied from 14,134 to 14,612. The term
‘drug’ in this context refers to a range of substances,
including volatile substances, but not alcohol. 
This data shows that young people’s admissions to
hospital as a result of drug or alcohol consumption is
an issue of concern. Many admissions may not relate
directly to overdose of alcohol or drugs but
nevertheless may warrant intervention to prevent
further physical or social harm. Information from the
USA illuminates how drinking can be linked to wider
social problems, and that admissions to hospital may
provide an opportunity to intervene. 
Young people admitted to Emergency Departments
in America with physical injuries are frequently
identified as having been drinking; in addition other
young people attend Emergency Departments as a
result of intoxication from alcohol (Kelly et al, 2004).
Young people are more likely to be involved in
physical fights if they drink or take drugs, this in turn
is associated with peers’ use of substances and
criminal activity such as selling drugs or gang
fighting (Kodjo et al, 2004). Problem drinking and
drinking with peers may be more closely associated
with physical fighting than frequent drinking and
binge drinking (Swahn et al, 2004).
A study in North America found that young people
were not routinely referred to drug and alcohol
services following admission to Emergency
Departments, even where their blood alcohol level
was positive and they had sustained an alcohol-
related injury (Mader et al, 2001). Several studies
have found that the screening instrument Alcohol
Use Disorders Identification Test (AUDIT) is useful for
assessing problematic drinking among young people
treated in Emergency Departments (Chung et al,
2000; Kelly et al, 2002 and Kelly et al, 2004). 
Kelly et al (2004) found that young people (16-20
years) treated in emergency departments for physical
assaults or alcohol intoxication were more likely to
be problematic alcohol drinkers (as defined by
AUDIT) than those admitted for illness, self-inflicted
or accidental injuries, even when they had also been
drinking. Those treated for physical assaults or
intoxication, who had drunk to the point of
intoxication once a month or more, were 15 times
more likely to be classified as problem drinkers. This
suggests that young people who present at
emergency departments with a physical assault
injury or alcohol intoxication and who also drink to
intoxication at least once a month should be
considered for referral to a misuse treatment service
(Kelly et al, 2004). AUDIT is being piloted in some
UK hospital settings with young people.
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Residential treatment for substance
misuse 
Young people’s residential interventions have been
found to be as effective as community-based ones
(Spooner et al, 2001; Dennis et al, 2004; Morral et
al, 2006). However, Jainchill et al (2005) warn that
residential services run as ‘therapeutic communities’
may not produce reductions in misuse one year after
starting the programme. Young people who have
participated in such communities do not rate them
well and have described them as demeaning and
alienating (Currie, 2003). Therapeutic communities
use positive peer role models and the peer
community to facilitate social and psychological
change; they often contain confrontational elements
to reduce aspects of a young person’s behaviour that
does not meet the programme’s strict boundaries.
Similar studies have not been conducted in the UK
so we cannot assume to draw similar conclusions
when comparing services in England. With regard to
‘therapeutic communities’ the study refers to a
specific type of service that engenders a hierarchical
regime where professionals and peers expect strict
adherence, leading to punitive action for small
infringements, such as being late. It is unlikely such
regimes exist in England; nevertheless it shows the
importance of understanding the regime and not
viewing all residential facilities as the same. 
Excluding young women with depression, who
appear to respond well to community services,
Godley et al (2004) suggest that young people with
a dual diagnosis of substance misuse and mental
health and/or those who regularly use heroin,
cocaine or alcohol may achieve better outcomes in
residential settings. However, other studies have
found similar outcomes in both community and
residential facilities (e.g. Morral et al, 2006).
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Good practice points
 Specialist harm reduction consists of
interventions to manage injecting behaviour,
overdose and accidental injury
 Needle exchange has been a core part of
drug treatment in the UK since the 1980s.
Needle exchange for young people should
take place only after a risk assessment, full
assessment, and as one element of a full 
care-planned treatment package
 Studies in the USA suggest that socially
excluded young people involved in drug
misuse understand the benefits of needle
exchange and do not consider it a barrier to
access other treatments. Young people who
have used needle exchange facilities are more
likely to have been injected by someone else,
found it hard to access needle exchange but
when they have accessed it are less likely to
share injecting equipment 
 Providing needle exchange to young people
may reduce risk-taking behaviour and has
been shown to improve access to other
aspects of drug treatment
 The NTA (2007b) Action Plan on Reducing
Drug Related Harm stresses the importance
of reducing deaths due to blood-borne
viruses (hepatitis B, C and HIV) as well as
from drug poisoning 
 Providing information and advice on how to
avoid drug-related deaths, including deaths
by solvent misuse, should be given to all
young people who use substances. It may
prevent risk taking and reduce the numbers
of drug-related deaths
 Drinking and drug taking behaviour among
young people is associated with admissions
to A&E departments. Alcohol-related
admissions among young people are
growing in England, while admissions related
to drug use remain high  
 Screening and risk assessment tools such as
AUDIT can identify young people with drug
and alcohol problems in A&E who need
referring to misuse services. The prompt for
screening is admission due to substance-
related intoxication or injury, including those
that are self-inflicted and caused by conflict. 
Good practice points
 In the USA, residential treatment services
have been shown to be as effective as other
community-based services 
 There have been negative appraisals of
‘therapeutic community’ services where
participants are punished for breaking rules
in a hierarchical system of peers and staff.
This type of regime should be avoided
 Intense residential services may help meet the
needs of young people with mental health
issues as well as substance misuse problems,
and of those with severe misuse problems. 
One of the greatest challenges in working with
young people to address their substance misuse is
encouraging them to engage with it at all, and then
working to maintain their attendance at treatment
services until they have achieved their goals or
moved on to other support networks. 
Understanding young people’s perspectives of
substance misuse treatment may help to break
down barriers to them accessing services. Some
young people may not feel that they have a problem
or need any help (Friedman et al, 2003), while
others have little or no concept of what substance
misuse treatment might be like (White et al, 2004).
Young people can have negative ideas about
substance misuse treatment, at best thinking it will
be boring, and at worst strictly run and even prison-
like (White et al, 2004). It is important to ensure that
these opinions are changed by winning the young
person’s confidence that the service offered will be
interesting and responsive to their needs, developed
in an arena of respect, trust and warmth.  
Setting goals
Following a full assessment of need, goals are set as
part of the care planning process. These goals
should be negotiated between the young person,
their parent and the practitioner. Some studies have
looked at expectations of substance misuse
treatment and can give us an insight into what is
important for young people, including some things
that are not always articulated at the initial stages. 
One of the most important things to young people
when accessing substance misuse treatment is that
staff are caring and committed, and able to be
flexible to their needs (Duroy et al, 2003). This staff
support appears to be more important than the type
of intervention given, as young people with
experience of different types of intervention could
come to no overall consensus on which type of
intervention they liked best or thought was most
helpful (Currie, 2003 and White et al, 2004). 
Setting treatment goals in a way that fully includes
the young person offers an opportunity to
demonstrate flexibility and your commitment to
caring for the young person. One study found that
young people mostly want to lower their levels of
substance consumption, but feel that their parents
would not accept this as they wanted abstinence or
a change in the young person’s attitude (White et al,
2004). This is likely to be an issue to debate with the
family so that realistic achievable goals can be set
that everyone understands the value of.  
Practitioners should not be put off if a young person
seems to have little motivation to change or does
not believe he or she has the skills to change; as
neither motivation (Friedman et al, 2003) nor self-
efficacy (Burleson and Kaminer, 2005) have been
shown to be good predictors of treatment outcome
in young people. Specialist substance misuse
treatment itself should boost confidence levels and
develop the young person’s ability to see that they
can make changes to their lives. 
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Good practice points
 Treatment providers should aim to make
their services interesting and responsive to
young people’s needs; gaining the
confidence of the young person by being
respectful, trustworthy and emotionally
warm. Staff should show that they care
about young people, are committed to
helping them, and flexible in helping to meet
each young person’s needs.
Good practice points
 Young people may show little motivation to
change, or feel that change is not possible.
Professionals need to support young people
to understand why change is desirable and to
develop confidence in their ability to change
 Treatment goals should be negotiated
between the young person, their parents,
and the practitioner. Initially, different people
may have different goals. It is important,
therefore, to discuss the goals in terms of
achievability and value to arrive at a suitable
compromise where required. 
Engaging and retaining
young people
Therapeutic alliance
The development of therapeutic alliance appears to
play an important factor in successful treatment
outcomes. It is defined as the collaborative and
effective bond between the therapist and patient. A
range of young people’s specialist substance misuse
treatment interventions have been shown to be
affected by therapeutic alliance (Shelef et al, 2005;
Tetzlaff et al, 2005; Hogue et al, 2006; Matrix and
the Institute for Criminal Policy Research, 2007).
Where the therapeutic alliance between the
therapist, the young people and their parents is
poor, young people in MDFT tend to drop out of
treatment rapidly (Robbins et al, 2006). 
The importance of therapeutic alliance is described
by practitioners working in England piloting arrest-
referral schemes with young people (Matrix and the
Institute for Criminal Policy Research, 2007). Key
features of success were:
 Allowing the young people to visit services
before they had committed to treatment
 Ensuring that the young people understood that
referrals to treatment were not compulsory
 Developing positive relationships with young
people
 Taking them to treatment services
 Not overwhelming the young people with long-
term plans.
In family-based treatment there is some debate
about whether therapeutic alliance is more effective
when developed more strongly with the parent or
the young person. As stated previously, establishing
an alliance between the therapist and the young
person is important. This can be achieved by
addressing the anxieties of the young person and
ensuring that their wishes are taken into account
(Shelef et al, 2005).
However, Shelef et al (2005) also stress that the
alliance between therapist and parent is also crucial
as not only does the parent usually bring their child
to sessions, he or she also has a strong desire for
change and can play an important part in bring
about change in the child. Where the therapist and
parent can agree on the treatment intervention, its
goals and tasks, the parent is more likely to engage
with the child emotionally and in daily interactions.
The young person may see this change in the
parents’ behaviour as being due to the involvement
of the therapist and consequentially feel a greater
affinity to the therapist, thus improving the alliance
between the therapist and the young person (Shelef
et al, 2005). This demonstrates the importance of
bringing the parents on board when undertaking
substance misuse treatment, in terms of reinforcing
the intervention in the home and in bringing about
more rapid changes in the family home than may be
achieved by working with the young person in
isolation.  
Shelef et al (2005) conclude that the parent-
therapist alliance has the greatest impact on
engaging the young person into treatment.
Thereafter the quality of the alliance between the
young person and therapist has the greatest impact
on the effectiveness of the treatment in terms of
substance misuse and other psychological
improvements. Hogue et al (2006) concur that the
therapeutic alliance with parents should initially be
emphasised, but then over time the alliance with the
young person should be emphasised. A strong
alliance between the therapist and the parent
initially produces the greatest reduction in substance
misuse and externalising mental health symptoms.
Improvements in externalising mental health
symptoms also occurred when the alliance between
the therapist and the young person developed as
treatment progressed. It appears that practitioners
delivering family-based interventions will have to
balance their development of therapeutic alliance
carefully to have the greatest effect. 
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Good practice points
 The development of a therapeutic alliance
between the professional and the young
person improves the effectiveness of
treatment outcomes. A therapeutic alliance
can be developed by addressing the anxieties
of the young person and ensuring that his or
her wishes are taken into account 
 When working with families, establishing a
therapeutic alliance between the professional
and the parents, as well as between the
professional and the young person, is
important. This can be approached in a
sequential way, first working on developing
an alliance between the professional and the
parent if this is considered to be important in
engaging the young person in treatment.  
Practical support and semi-formal
contact
Establishing regular contact with a young person
and offering practical support to overcome barriers
to treatment engagement has been shown to be
effective in improving treatment interventions.
However, activity of this type it is not classed as a
therapeutic intervention in itself and should be
provided as an engagement aid alongside
therapeutic interventions. In North American
literature this activity is described as ‘case
management’ but this could be confused with ‘care
management’ or ‘care planning’ in England, which
are specific interventions with their own definitions.
The term ‘practical support and semi-formal contact’
will be used here. The practical support described
below should be seen as one element of ‘key-
working’ as understood in England. 
Practical support and semi-formal contact sessions
have been shown to increase engagement and
retention in substance misuse treatment (Noel,
2006). In Noel’s study, weekly sessions were
arranged, in addition to any other therapeutic
interventions, purely to concentrate on eliminating
any issues that may be a barrier to effective
treatment engagement. The sessions were held in
places that the young person had no difficulty
attending, such as their own home or local
community resources. Issues tackled in these
sessions included but were not limited to:
 Planning and co-ordinating other interventions
 Ensuring young people attended their
interventions and had no difficulties with them
 Acting as an advocate for the young person
 Transportation to treatment interventions
 Helping with housing or other social factors.
In some cases the person providing this service was
also providing therapeutic interventions, but these
were conducted separately so these sessions could
be more informal and relaxed. It is interesting to
note that in another study young people said they
valued the opportunity to have informal contact
with practitioners so that they could see that they
were ‘real people’ (Duroy et al, 2003).
Noel (2006) suggests that this type of support may
be particularly beneficial to groups generally difficult
to engage such as young women, young people
from black and minority ethnic (BME) communities
and those with mental health problems. 
Group work
The use of therapeutic group work with young
people is not widely implemented in England,
though it is regularly used in the USA. Concerns
about confidentiality between group members and
information being used to manipulate others may
have influenced decisions about the appropriateness
of group work. These fears are echoed by young
offenders in custodial settings in the USA (Stathis et
al, 2006), but an evaluation of community-based
services for young offenders in England and Wales
recognised the value of group work (Hammersley et
al, 2004). However, some of these groups proved
difficult to run due to narrow inclusion criteria,
which kept the attendance too low. Hammersley et
al (2004) suggest that incorporating substance
misuse into generic group work on health or
offending may mitigate these effects. 
Evaluations of therapeutic group work in North
America found it to be as effective as individual
therapy and did not note any negative effects
(Dennis et al, 2004), even when including young
people with conduct disorder (Kaminer et al, 2002).  
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Good practice points
 Providing practical support and semi-formal
contact to young people can help them
access the more formal aspects of treatment
 Examples of practical support and semi-
formal contact are: planning other
interventions; helping young people attend
treatment; checking treatment progress;
advocacy; helping access to social support
 Practical support and informal contact may
be useful in helping young people who are
hard to engage in treatment.
Good practice points
 Concerns about the negative consequences
of therapeutic group work with young
misusers may have been exaggerated
 Therapeutic group work can be effective,
provided sufficient numbers attend
 Therapeutic group work on substance misuse
could be incorporated into groups addressing
wider health or social issues.
Aftercare
Aftercare describes what happens after young
people are released from custodial sentences,
complete community sentences and/or leave
treatment. Specialist treatment is one of many
services that are required to support the changes
made in relation to substance misuse. 
The effectiveness of specialist substance misuse
treatment interventions in reducing substance
misuse appears to change over time from the start
of treatment, which has important implications for
aftercare interventions. The periods discussed in this
section describe the time lapse since the
commencement of treatment, not treatment length.
The length of treatment varied between
interventions in each study, but differences in
treatment effectiveness were not found between
interventions. 
Substance misuse reduces most quickly in the first
three months following the initiation of treatment
(Dasinger et al, 2004 and Dennis et al, 2004). Over
the following nine months (i.e. after a year from
commencement) there is a gradual return to
substance misuse but it remains at levels lower than
were originally the case. This suggests that while
substance misuse treatment is effective, the effects
diminish over time and cannot prevent all substance
misuse or problems for young people (Dennis et al,
2004). Brown (2004) found that despite the shorter
history of substance misuse problems that young
people present compared to adults, they have similar
levels of relapse in the first year following treatment.
Farabee et al (2001) compared young people
receiving substance misuse treatment who were
being monitored by the criminal justice system with
young people receiving treatment not being
monitored by the criminal justice system. They found
that while alcohol and cannabis use had reduced
after a year for both groups, those not being
monitored by the criminal justice system had
increased their heroin and cocaine use. This increase
in substance use was small, but statistically
significant. 
While Rowe et al (2004) found that there may even
be increases in substance misuse during treatment,
by six months the misuse had reduced to levels
lower than at the start of treatment. 
The current evidence base is not able to account for
these fluctuations in patterns of use over the one
year period. Measham et al (1998) may offer some
clues: they looked at young people not in treatment
in England and found that there were fluctuations in
use over time. Brown (2004) suggests that the
relapses may be due to a range of factors such as
changes in the young person’s environment,
fluctuating motivation, or skills deficits. Further
research is clearly needed in this area.
Whatever the reasons for relapse or increases in
substance misuse, what is clear is that follow-up
support and aftercare interventions could offer
opportunities to bolster and reinforce the messages
from treatment interventions. This could in turn
reduce the number, length and severity of relapses
and increases in substance misuse. Godley et al
(2004) suggests that those over 15 years old and
young people with conduct disorder are more likely
to require aftercare support to maintain treatment
benefits.
Transitions
A transition is the process of moving from one
service to another. This can be from young people’s
services to adult services, residential services to
community services, or specialist services to universal
services. The evidence in relation to transitions is all
from North America and concerns the transition
from residential to community services, and the
transition between high and low-intensity
community services. It is difficult to widely apply the
findings of these studies to an English setting where
there is little residential or daily high-intensity
specialist substance misuse treatment. However,
those young people leaving residential services,
including custodial establishments where they have
received substance misuse treatment, may benefit
from the lessons of these studies, as might those
exiting community-based services. Continuity of
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Good practice points
 Substance misuse treatment is effective, but
the effects diminish over time and cannot
prevent all substance misuse or problems for
young people
 As with adults, young people are likely to
relapse, which can occur during treatment or
following it. However, rates of substance
misuse are still likely to be lower than before
treatment
 Regular contact and monitoring of young
people has been shown to reduce the return
to substance misuse. Aftercare interventions
offer opportunities to bolster and reinforce
the messages from treatment interventions.
substance misuse services has been shown to be
poor for young people leaving custodial
establishments in England and Wales (Pitcher et al,
2004). 
Wood et al (2002) explored the experiences of staff
working in residential services. The staff felt planning
to prepare young people for the transition to
community living needed to be done well in advance
of the actual departure. The planning process should
include the young person, their family, health and
education services to identify needs and plan services
to meet them. 
Duroy et al (2003) interviewed young people
involved with a long-term (three years) stepped-care
substance misuse treatment model. The model
consisted of a residential phase, an intensive daily
community phase, and a lower intensity community
intervention (at least two groups per week). They
found that young people with severe substance
misuse problems such as a history of previous
treatment, or a history of heroin, cocaine or regular
alcohol use, found the transition to a less intense
form of substance misuse treatment or ending
treatment very stressful. Factors precipitating the
stress were different when leaving residential service
compared to when reducing the intensity of
community treatment, but stress was evident at
both stages. 
Returning to the community, young people were
concerned with:
 Returning to difficult family situations
 Loosing the support of the residential service
 Meeting peers who were still using substances.
Adjustment was difficult for some as their families
had not always changed, or not to the same extent
as the young person, and family members found it
difficult to recognise the changes in the young
person (Duroy et al, 2003).
Young people were able to identify factors that
eased the stress of changing to a lower intensity
community substance misuse treatment service.
Particularly important was being in training or
employment, which increased their feeling of self-
reliance and developing independence (Duroy et al,
2003). 
Godley et al (2002, 2007) found that providing
practical and informal support helped ease the
transition from residential to community
programmes, improving retention in services and
reducing the return to substance misuse. Increasing
communication skills, problem solving and
encouraging pro-social activities all support the
transition period (Godley et al, 2002). However,
these interventions may have to be continued for
longer than three months (Godley et al, 2007). 
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Good practice points
 Transition between services and discharge
planning should be started well in advance of
the transition/discharge date, particularly
when leaving residential services, reducing
the intensity of services, or being discharged
from treatment completely  
 Young people find transition to new services
stressful. Leaving residential services raises
issues about stresses and triggers in the
community, such as family circumstances and
mixing with substance misusing peers again
 Engaging family members in preparing to
have the young person at home again may
relieve some of the stress, as will finding
positive activities for young people to engage
with, including education, training and
employment 
 Providing practical support and informal
contact over an extended period of time may
be required to support the transition. 
This section describes substance treatment related
research on specific groups of young people,
demonstrating additional vulnerabilities to that of
substance misuse and effective treatment
interventions. There are a number of groups of
young people who are considered vulnerable to
developing substance misuse problems (NICE,
2007c). Not all of those groups are reflected here, 
as the determining factor was young people
participating in substance misuse treatment
intervention research for special populations rather
than vulnerability to substance misuse. Similarly
young women who are pregnant present a service
with additional complications, but there is no
specific research on this group and practitioners
have only adult treatment recommendations (e.g.
Department of Health, 2007b) to refer to at present. 
Young women
A number of studies have shown that young women
who come into contact with specialist substance
misuse treatment services and the criminal justice
system may have more severe substance misuse and
mental health problems than young men. 
In England and Wales, studies have been conducted
in relation to criminal justice settings, on arrest or in
custody. Douglas and Plugge (2006) found that over
a third of young women in custody had recently self-
harmed and that many are vulnerable to sexual
exploitation. Other studies suggest that young
women are more likely than young men to:
 Test positive for Class A drugs on arrest (Matrix
and The Institute for Criminal Policy Research,
2007)
 Have self-harmed both before and while in
custody (Galahad SMS Ltd., 2004)
 Be vulnerable to health problems, more likely
have mental health and/or substance misuse
problems, more likely to use heroin, crack or be
poly-substance misusers while in custody
(Douglas and Plugge, 2006). 
Similar patterns of mental health problems and
severe substance misuse have been found in
specialist substance misuse treatment settings in the
USA. Young women in comparison to young men
have been found to have:
 More severe substance misuse problems (Ruiz et
al, 2005)
 Needs in addition to substance misuse, such as
mental health problems and family dysfunction
(Rowe et al, 2004)
 More severe mental health problems (Ruiz et al,
2005).  
These studies represent levels of need among young
women who come into contact with services.
However, there is little known about how treatment
could be tailored differently to be more effective for
young women. Two studies give some indications.
Noel (2006) found that young women may respond
well to “practical support and semi-formal contact”,
(termed ‘case management’ in the USA). This
strategic approach, which ensures that barriers to
treatment are overcome and provides assistance to
access treatment, helped young women with
multiple problems engage with, and stay in,
treatment. 
Reihman et al (2003) interviewed young women in
specialist treatment in the USA about their social
relationships and their ability to gain support from
social networks. Despite the interview not specifically
asking anything about sexuality, they found that
where young women had social relationships with
men they operated on a highly sexual basis and
offered little in the way of support. These same
young women also gained little support from their
same-sex friendships within the residential
programme as there were concerns about gossiping
and conflicts in sexual relationships that may develop
with the young men on the programme. Overall,
Riehman et al (2003) found that young men were
more likely to gain social support from both same
and opposite-sex relationships than young women in
residential treatment settings. They therefore
suggest that young women may be more likely to
respond better in one-to-one sessions rather than
group work and that they may need support in
building their friendship skills.
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Developments for 
special groups
Mental health 
When people have a substance misuse problem and
a mental health problem it is often referred to as a
dual diagnosis or co-morbidity. Studies in the UK are
restricted to custodial settings where high levels of
dual diagnosis have been found (Galahad SMS Ltd.,
2004). Young women seem to be particularly
vulnerable to this, engaging in higher levels of self-
harm than young men (Galahad SMS Ltd., 2004;
Douglas and Plugge, 2006). The vulnerability to dual
diagnosis among young women is seen in the
increased incidence of post-traumatic stress disorder
(PTSD), depression and suicide (Douglas and Plugge,
2006). These studies are supported by findings in
the USA, where Abrantes et al (2005) found high
levels of dual diagnosis in custodial settings and
increased severity of both substance misuse and
mental health problems among young women.
Studies from other countries show that dual
diagnosis among young people is associated with:
 Earlier onset of misuse (Rowe et al, 2004)
 A poor ability to cope with misuse, even though
levels of use may be lower than peers without
mental health problems (Tomlinson et al, 2004)
 Family dysfunction and parents with drug or
alcohol problems (Grella et al, 2001, and Rowe
et al, 2004).
Mental health symptoms may appear to increase
among those with pre-existing mental health
problems who also use substances, requiring greater
resources from treatment settings (Stathis et al,
2006). Early identification and treatment of dual
diagnosis is required to produce better treatment
outcomes for this group, who tend to have more
severe substance misuse problems and multiple
treatment episodes (Grella et al, 2001). 
Young people with dual diagnosis may be less likely
to do well in substance misuse treatment than those
without mental health problems (Grella et al, 2001;
Rowe et al, 2004, and Tomlinson et al, 2004). This
may be because they are more likely to relapse
(Rowe et al, 2004, and Tomlinson et al, 2004) or
because depressive symptoms are quite resilient to
change (Grella et al, 2001).
However, other studies have found that young
people with dual diagnosis can be engaged in
treatment (Noel, 2006), and that this treatment can
be effective at reducing substance misuse and
mental health symptoms (Kaminer and Burleson,
2004).
There are particular difficulties regarding the use of
pharmacological treatments with young people who
have a dual diagnosis.
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Good practice points
 Young women who come into contact with
specialist substance misuse treatment or
criminal justice services may have more
severe substance misuse problems than
young men in similar circumstances. They are
also more likely to have mental health
problems and be vulnerable in other ways,
such as exposure to sexual exploitation. Care
should be used to ensure that assessments
are sensitive, yet thorough, in helping to
identify needs in young women
 Young women may need extra support to
access services that meet their needs, and
help to establish supportive relationships
from peers
.  
 Young women with multiple problems may
benefit more from one-to-one services than
from group work.
Good practice points
 Dual diagnosis, or co-morbidity, of substance
misuse and mental health problems is high
among young people who have substance
misuse problems 
 Having a dual diagnosis is associated with
additional risk factors, such as early onset of
substance misuse, less ability to cope with
using substances and family difficulties
 Early identification of mental health problems
is encouraged to help improve the possibility
of effective substance misuse treatment.
Establishing access to treatment services may
be difficult and may require providing
practical support and informal contact
 Working with young people with a dual
diagnosis requires expertise from substance
misuse and mental health professionals;
collaborative working between services
and/or professionals is required. 
Young offenders 
Studies in the UK reliably show that substance
misuse is more common among young people
involved in the criminal justice system than those
who are not involved in offending behaviour. While
the general pattern of substance misuse remains
similar, in that the most common substances used
are cannabis and alcohol, the levels of young people
involved in such activities and in taking Class A drugs
are much higher than in general youth comparison
groups (Hammersley et al. 2003; Galahad SMS Ltd,
2004; Matrix and The Institute for Criminal Policy
Research, 2007).
In criminal justice policy the links between substance
misuse and crime are largely accepted, however this
does not make it a simple causal relationship
(Seddon, 2006). Studies of young people’s substance
misuse treatment often take place in the context of
criminal justice interventions and attempt to
establish a link between substance misuse treatment
and reduction in criminal behaviour. A number of
studies have demonstrated that involvement in
substance misuse treatment can lead to a drop in
criminal activity (Jainchill et al, 2005; Henggeler et al,
2002; Farabee et al, 2001); however, this is based
on self-report criminal activity. 
Despite the potential problems with using self-report
data the studies had some interesting findings.
Farabee et al (2001) found that being supervised by
a criminal justice agency was associated with a
reduction in drug-related crime compared to those
who also underwent substance misuse treatment
but were not supervised in this way. This was
despite the fact that the young people who were
supervised by the criminal justice agency were more
likely to have committed more crimes before the
intervention, have criminally active families and
peers, and meet the diagnosis for conduct disorder.
However, Henggeler et al (2002) found that Multi-
systemic therapy for substance misuse produced
reports of a drop in violent crime but not property
crime.
There is no irrefutable evidence that substance
misuse treatment produces a reduction in criminal
convictions in young people. However, these
promising findings about self-reported drops in
criminal activity, along with the link between
substance misuse and crime, should encourage
professionals to consider that substance misuse
treatment is a valid intervention for those who have
identified needs. 
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Good practice points
 There is an established but complex link
between substance misuse and criminal
activity
 Young people who offend are more likely to
use substances than young people who do
not offend.
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The aim of this document was to produce a
synthesis of the evidence on effective substance
misuse treatment for young people. A systematic
approach was used to gather source materials for
the review. Among the criteria for sourcing and
including literature were:
 Searching for peer review journal research data
and grey literature published since 2001
 Invitations to key informants and other
professionals working in appropriate research,
policy and practice fields to contribute studies
including in-house evaluations
 Selecting studies that were appropriate to
substance misuse treatment interventions in
England, treatment as defined by the NTA 
 Reviewing and appraising studies based on
established grading systems
 Including systematic reviews to support topics
where evidence was low or absent since 2001,
so that studies published prior to 2001 could be
included where they were required.
Search strategy
A literature review is most effective when a clear
search strategy has been developed. A systematic
approach to searching and grading the evidence was
adopted for the development of this report. The
search strategy involved identifying a list of
databases that had abstracts, references or full
details of research articles in the social sciences,
medicine and criminal justice arenas. Key terms were
used in the search, developed to be in-keeping with
the elements of substance misuse interventions
considered to fall under the remit of ‘treatment’ and
those proposed at a national consultation event held
by the NTA. Key terms included ‘young people’,
‘adolescents’ and ‘adolescence’ as the review was
only to include those studies based on data from a
population of people under 18 years old or where a
large proportion of the sample were under 18. 
The database search was supplemented by other
tactics. Reference lists of journal articles were
searched, and in-journal searches were undertaken.
In addition numerous websites were searched for
non-peer review but published work as well as grey
literature searches undertaken in specialist libraries.
Validation
Initial searches identified many sources but it
became clear that many were descriptive of
prevalence, risk factors, and trends in substance
misuse as opposed to focusing on impact,
effectiveness and intervention approaches. These
studies were therefore excluded.
Initial assessment of the abstracts led to the
identification of nearly 600 studies to include in the
full rating process. The rating process used explicit
methods to appraise and analyse the identified
studies. Full text copies of the materials were
gathered for appraisal and analysis, all literature was
graded independently by two researchers. Any
disputes regarding grading were discussed in detail
before final agreement was reached. 
Grading for the quantitative studies was based on
an adapted version of the Scientific Maryland Scale
(SMS) to include comparison as well as control
groups, as control groups were generally not evident
in the studies. Table 1 demonstrates the grading
table, with studies being rated as 5 being the most
robust and those graded 1 the least. 
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Appendix: Methodology
Standard Description
Level 5 Randomised control trial i.e. pre
and post intervention measures in
treatment and control /
comparison group, with
participants randomised to
treatment and control /
comparison groups.
Level 4 Pre and post intervention
measures in treatment and
control / comparison group, and
analysis also controls for other
factors that influence outcome.
Level 3 Pre and post intervention
measures in treatment and
control / comparison group.
Level 2 Includes pre and post
intervention measures but with
no control / comparison group.
Level 1 Includes studies reporting an
outcome measure with an
intervention group assessed at
one point in time only.
Table 1: Scientific Maryland Scale (adapted )
Grading from the qualitative studies was conducted
using the Global Assessment of Evaluation Quality
(GAEQ) scale. To derive a score, each study was
assessed on the dimensions listed in Table 2. The
presence of each dimension scored a point on the
scale. A score of zero on an item implies low or poor
rating, higher scores imply greater methodological
robustness. Possible scores were 0-5. 
Inclusion in the report
All studies identified were graded. This included peer
reviewed articles and grey literature. Following
grading against the SMS or the GAEQ, studies that
scored less than three were excluded. In addition the
evidence was supplemented where there were gaps
in research by reviews of the evidence base where
these were justified in terms of their systematic
nature and scoring criteria. Often these provided
evidence from an earlier time than 2001 so
expanded the timeframe for publication. 
Research was assimilated into the report according
to the NTA’s definition of interventions that include
treatment (Chapter 2). Other studies were included
that focused on the quality of developing
relationships with young people with substance
misuse problems (Chapter 3).
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Dimension Description
Measures /
data collection
tools
Specified and standardised data
collection tools (e.g. written topic
guides, aide memoirs, etc.)
Sample
representat-
iveness
Adequate representativeness of
sample relative to analytic
dimensions (in sense of cross-
section, not statistical
representativeness) e.g. not all
‘volunteers’, not all one type of
person when an intervention is
delivered to a range of people
Sample size Adequate sample size in relation
to conclusions draw (especially
regarding sub-groups i.e. not less
than n=5)
Analytic
methods
Proper data capture methods
(tapes, notes) and appropriate
and specified methods of analysis
(e.g. grounded theory, content
analysis, framework analysis,
thematic, etc.)
Programme
integrity
External or independent
evaluation
Table 2: GAEQ scale
